A counterintuitive antibody cocktail disrupts coxsackievirus

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

(2022) Laura A. VanBlargan et al.   NATURE MEDICINE

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

(2022) Qingbing Zheng et al.   Cell Host & Microbe

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

(2021) Delphine Planas et al.   NATURE

Pan-ebolavirus protective therapy by two multifunctional human antibodies

(2021) Pavlo Gilchuk et al.   CELL

Potently neutralizing and protective human antibodies against SARS-CoV-2

(2020) Seth J. Zost et al.   NATURE

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

(2020) Alina Baum et al.   SCIENCE

Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease

(2020) Matthew R. Vogt et al.   Science Immunology

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

(2020) Peter Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

(2019) Sabue Mulangu et al.   NEW ENGLAND JOURNAL OF MEDICINE